Clinical Trial Update: Study of BEST1 Vitelliform Macular Dystrophy

View source ↗

Summary

Clinical trial update announcing recruitment for BEST1-related vitelliform macular dystrophy study sponsored by Columbia University.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Best Vitelliform Macular Dystrophy
• Retinitis Pigmentosa

Snippet

Sponsor: Columbia University | Conditions: Best Vitelliform Macular Dystrophy, Retinitis Pigmentosa | Status: RECRUITING